Design Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filers
137
Total reported value, excl. options
$737M
Manager Report Date Value ($000) Shares